Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
February 28, 2013
Primary Completion Date
April 30, 2013
Study Completion Date
May 31, 2013
Conditions
Breast CancerVaginal DrynessDyspareuniaSexual Health Quality of Life
Interventions
DRUG
Testosterone
Trial Locations (1)
68130
Nebraska Cancer Specialists/Midwest Cancer Center - Legacy, Omaha
All Listed Sponsors
lead
Creighton University
OTHER
NCT01697345 - Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy | Biotech Hunter | Biotech Hunter